RRP has only one major SH with 85%, so small SH will have to agree to whatever terms Taurus dictated. B2Y has two major SH and it will cost a lot more to buy out. This is more like AGO.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025